Published in J Cell Biol on July 01, 1989
Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest (1996) 2.51
P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci U S A (1994) 2.00
Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time. J Trauma (2009) 1.76
Cytoplasmic domain of P-selectin (CD62) contains the signal for sorting into the regulated secretory pathway. Mol Biol Cell (1992) 1.48
Expression of tissue factor procoagulant activity: regulation by cytosolic calcium. Proc Natl Acad Sci U S A (1990) 1.42
Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway. J Cell Biol (1996) 1.41
Antibody mapping of tissue factor implicates two different exon-encoded regions in function. Biochem J (1991) 1.30
Synergies of phosphatidylserine and protein disulfide isomerase in tissue factor activation. Thromb Haemost (2014) 1.29
Cellular localization and trafficking of tissue factor. Blood (2006) 1.23
Temporal expression of alternatively spliced forms of tissue factor pathway inhibitor in mice. J Thromb Haemost (2009) 1.20
Tissue factor expression in human arterial smooth muscle cells. TF is present in three cellular pools after growth factor stimulation. J Clin Invest (1997) 1.18
Coupling of the adhesive receptor CD11b/CD18 to functional enhancement of effector macrophage tissue factor response. J Clin Invest (1991) 1.16
Intracellular and surface distribution of monocyte tissue factor: application to intersubject variability. Arterioscler Thromb Vasc Biol (2005) 1.14
Rapid activation of monocyte tissue factor by antithymocyte globulin is dependent on complement and protein disulfide isomerase. Blood (2013) 1.07
Tissue factor pathway inhibitor-gamma is an active alternatively spliced form of tissue factor pathway inhibitor present in mice but not in humans. J Thromb Haemost (2008) 1.02
Glomerular tissue factor expression in crescentic glomerulonephritis. Correlations between antigen, activity, and mRNA. Am J Pathol (1995) 1.02
Alternatively spliced isoforms of tissue factor pathway inhibitor. Thromb Res (2010) 0.98
Tissue factor trafficking in fibroblasts: involvement of protease-activated receptor-mediated cell signaling. Blood (2007) 0.97
Tissue factor encryption and decryption: facts and controversies. Thromb Res (2012) 0.96
Lessons from the aprotinin saga: current perspective on antifibrinolytic therapy in cardiac surgery. J Anesth (2009) 0.96
Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cells. Biochem J (1992) 0.93
Two sites in the tissue factor extracellular domain mediate the recognition of the ligand factor VIIa. Proc Natl Acad Sci U S A (1991) 0.92
How it all starts: Initiation of the clotting cascade. Crit Rev Biochem Mol Biol (2015) 0.87
Tissue factor: mechanisms of decryption. Front Biosci (Elite Ed) (2012) 0.85
Enhancement of fibrinogen-triggered pro-coagulant activation of monocytes in vitro by matrix metalloproteinase-9. Thromb J (2010) 0.84
Adiponectin inhibits macrophage tissue factor, a key trigger of thrombosis in disrupted atherosclerotic plaques. Atherosclerosis (2012) 0.84
Mycobacterium tuberculosis infection and tissue factor expression in macrophages. PLoS One (2012) 0.84
Urinary tissue factor in glomerulonephritis: a potential marker of glomerular injury? J Clin Pathol (1997) 0.83
Excess of heme induces tissue factor-dependent activation of coagulation in mice. Haematologica (2015) 0.82
The third Trp-Lys-Ser (WKS) tripeptide motif in tissue factor is associated with a function site. Biochem J (1992) 0.80
Tissue Factor/Factor FVII Complex Inhibitors in Cardiovascular Disease. Are Things Going Well? Curr Cardiol Rev (2010) 0.80
Procoagulant activity after exposure of monocyte-derived macrophages to minimally oxidized low density lipoprotein. Co-localization of tissue factor antigen and nascent fibrin fibers at the cell surface. Am J Pathol (1995) 0.78
Fusion of the tissue factor extracellular domain to a tumour stroma specific single-chain fragment variable antibody results in an antigen-specific coagulation-promoting molecule. Biochem J (2000) 0.77
Tissue factor-dependent and -independent pathways of systemic coagulation activation in acute myeloid leukemia: a single-center cohort study. Exp Hematol Oncol (2015) 0.77
Factor VIIa interaction with tissue factor and endothelial cell protein C receptor on cell surfaces. Semin Hematol (2008) 0.75
Effects of astragalus polysaccharide on the adhesion-related immune response of endothelial cells stimulated with CSFV in vitro. PeerJ (2017) 0.75
Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem (1980) 28.03
Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med (1986) 17.64
Monoclonal antibodies against simian virus 40 T antigens: evidence for distinct sublcasses of large T antigen and for similarities among nonviral T antigens. J Virol (1980) 7.51
Membrane asymmetry. Science (1977) 5.12
Stimulated mobilization of monocyte Mac-1 and p150,95 adhesion proteins from an intracellular vesicular compartment to the cell surface. J Clin Invest (1987) 3.40
Mitogenic activity of blood components. I. Thrombin and prothrombin. Proc Natl Acad Sci U S A (1975) 3.20
Tissue factor and hemostasis. Blood (1988) 3.15
Interleukin-1 activation of vascular endothelium. Effects on procoagulant activity and leukocyte adhesion. Am J Pathol (1985) 2.59
Tissue-factor coagulant activity of cultured human endothelial and smooth muscle cells and fibroblasts. Blood (1977) 2.30
Monocyte chemotaxis: stimulation by specific exosite region in thrombin. Science (1983) 2.28
The endotoxin-induced coagulant activity of human monocytes. Br J Haematol (1975) 2.27
Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade. Cell (1987) 2.09
Monoclonal antibody analysis of purified and cell-associated tissue factor. Thromb Res (1988) 2.00
Tissue factor revisited. Prog Hemost Thromb (1982) 1.86
Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA. Proc Natl Acad Sci U S A (1987) 1.71
Binding of human factor VII and VIIa to monocytes. J Clin Invest (1982) 1.60
Mononuclear cell tissue factor: cell of origin and requirements for activation. Blood (1979) 1.58
The phospholipid requirement of tissue factor in blood coagulation. J Clin Invest (1968) 1.57
Hemostatic properties of normal and perturbed vascular cells. FASEB J (1988) 1.54
Association of tissue factor activity with the surface of cultured cells. J Clin Invest (1975) 1.52
The production and availability of tissue thromboplastin in cellular populations of whole blood exposed to various concentrations of endotoxin. An assay for detection of endotoxin. Scand J Haematol (1982) 1.51
Coagulant activity of leukocytes. Tissue factor activity. J Clin Invest (1972) 1.50
Human tissue factor: cDNA sequence and chromosome localization of the gene. Biochemistry (1987) 1.43
Isolation and characterization of human factor VII. Activation of factor VII by factor Xa. J Biol Chem (1981) 1.37
Ultrastructural antibody localization of alpha2-macroglobulin in membrane-limited vesicles in cultured cells. Proc Natl Acad Sci U S A (1978) 1.33
Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells. Cancer Res (1983) 1.29
Combined functional and immunochemical analysis of normal and abnormal human factor X. J Clin Invest (1979) 1.27
Quantitation of factor VII in the plasma of normal and warfarin-treated individuals by radioimmunoassay. Blood (1983) 1.23
Monocyte procoagulant inducing factor: a lymphokine involved in the T cell-instructed monocyte procoagulant response to antigen. J Immunol (1986) 1.14
Resolution of monomeric and heterodimeric forms of tissue factor, the high-affinity cellular receptor for factor VII. Thromb Res (1988) 1.12
Evidence for tissue factor-dependent activation of the classic extrinsic coagulation mechanism in blood obtained from bleeding time wounds. Blood (1988) 1.11
Cloning and expression of human tissue factor cDNA. Thromb Res (1987) 1.11
Receptor-mediated endocytosis. J Clin Invest (1986) 1.11
The collisional limit: an important consideration for membrane-associated enzymes and receptors. FASEB J (1988) 1.08
Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes. Blood (1988) 1.08
Cooperative interaction between factor VII and cell surface-expressed tissue factor. J Biol Chem (1987) 1.01
Tissue factor activity of normal and neoplastic cells: quantitation and species specificity. J Natl Cancer Inst (1983) 0.99
Coagulation and the expression of cell-mediated immunity. Immunol Cell Biol (1987) 0.98
Structural features of endotoxin required for stimulation of endothelial cell tissue factor production; exposure of preformed tissue factor after oxidant-mediated endothelial cell injury. J Lab Clin Med (1985) 0.94
Tissue factor apoprotein: intracellular transport and expression in shed membrane vesicles. Thromb Res (1987) 0.92
Thromboplastin (tissue factor) in plasma membranes of human monocytes. Biochem J (1985) 0.89
Antimetastatic agents. I. Role of cellular procoagulants in the pathogenesis of fibrin deposition in cancer and the use of anticoagulants and/or antiplatelet drugs in cancer treatment. Semin Thromb Hemost (1988) 0.88
Tissue factor activity in HeLa cells measured with a continuous chromogenic assay and ELISA reader. Thromb Res (1986) 0.87
Thrombin cleavage of extracellular matrix proteins. Ann N Y Acad Sci (1986) 0.86
Mediation of cellular events by thrombin. Int Rev Exp Pathol (1986) 0.84
Regulatory roles of T mu and T gamma cells in the collaborative cellular initiation of the extrinsic coagulation pathway by bacterial lipopolysaccharide. J Clin Invest (1985) 0.84
An intracellular pool of the procoagulant thromboplastin in human monocytes. Thromb Res (1985) 0.77
Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal Biochem (1981) 29.21
Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol (1989) 5.41
Autologous immune complex nephritis induced with renal tubular antigen. I. Identification and isolation of the pathogenetic antigen. J Exp Med (1968) 4.79
Autologous immune-complex pathogenesis of experimental allergic glomerulonephritis. Science (1967) 3.96
A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene (2006) 3.89
Human platelets possess an inducible and saturable receptor specific for fibrinogen. J Biol Chem (1979) 3.61
Autologous immune complex nephritis induced with renal tubular antigen. II. The pathogenetic mechanism. J Exp Med (1968) 3.40
Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. J Biol Chem (1997) 2.73
Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Science (1997) 2.59
Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest (1996) 2.51
Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock (1991) 2.49
POLYCYSTIC KIDNEY. Ann Surg (1926) 2.38
Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade. Biochemistry (1989) 2.29
The structural biology of expression and function of tissue factor. Thromb Haemost (1991) 2.28
Oligospecificity of the cellular adhesion receptor Mac-1 encompasses an inducible recognition specificity for fibrinogen. J Cell Biol (1988) 2.28
Characterization and isolation of specific renal tubular epithelial antigens. J Immunol (1967) 2.25
Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites. J Exp Med (1991) 2.10
Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade. Cell (1987) 2.09
Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor. Proc Natl Acad Sci U S A (2001) 2.07
Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc Natl Acad Sci U S A (1992) 2.07
Interaction of fibrinogen with its platelet receptor as part of a multistep reaction in ADP-induced platelet aggregation. J Biol Chem (1980) 2.05
Monoclonal antibody analysis of purified and cell-associated tissue factor. Thromb Res (1988) 2.00
Lymphocyte cooperation is required for amplification of macrophage procoagulant activity. J Exp Med (1980) 1.90
The saturable high affinity association of factor X to ADP-stimulated monocytes defines a novel function of the Mac-1 receptor. J Biol Chem (1988) 1.89
Evidence for a B lymphocyte defect underlying the anti-X anti-erythrocyte autoantibody response of NZB mice. J Immunol (1977) 1.82
Immunochemical heterogeneity of human plasma apolipoprotein B. I. Apolipoprotein B binding of mouse hybridoma antibodies. J Biol Chem (1982) 1.80
Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis. J Clin Invest (1998) 1.73
Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function. J Biol Chem (1991) 1.67
Relationship between markers of activated coagulation, their correlation with inflammation, and association with coronary heart disease (NPHSII). J Thromb Haemost (2007) 1.67
Lymphocyte E rosette inhibitory factor: a regulatory serum lipoprotein. J Exp Med (1975) 1.66
Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am J Pathol (1998) 1.65
Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice. J Exp Med (1981) 1.62
Two-stage response to endotoxin infusion into normal human subjects: Correlation of blood phagocyte luminescence with clinical and laboratory markers of the inflammatory, hemostatic response. Crit Care Med (2001) 1.61
Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol (1989) 1.61
The assessment by immunofluorescence methods of humoral anti-myelin antibodies in man. J Immunol (1970) 1.61
Allogeneic induction of the human T cell-instructed monocyte procoagulant response is rapid and is elicited by HLA-DR. J Exp Med (1983) 1.60
Determination of the von Willebrand's disease antigen (factor VIII-related antigen) in plasma by quantitative immunoelectrophoresis. J Lab Clin Med (1975) 1.54
The integrity of the cysteine 186-cysteine 209 bond of the second disulfide loop of tissue factor is required for binding of factor VII. J Biol Chem (1991) 1.54
Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells. J Clin Invest (1980) 1.53
Murine lymphoid procoagulant activity induced by bacterial lipopolysaccharide and immune complexes is a monocyte prothrombinase. J Exp Med (1982) 1.53
Integrin regulation of leukocyte inflammatory functions. CD11b/CD18 enhancement of the tumor necrosis factor-alpha responses of monocytes. J Immunol (1993) 1.52
A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280. J Cell Biol (1998) 1.51
A recombinant human enzyme for enhanced interstitial transport of therapeutics. J Control Release (2006) 1.51
Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest (1994) 1.50
Correlation of factor VIIa values with factor VII gene polymorphism, fasting and postprandial triglyceride levels, and subclinical carotid atherosclerosis. Circulation (1999) 1.49
A unique recognition site mediates the interaction of fibrinogen with the leukocyte integrin Mac-1 (CD11b/CD18). J Biol Chem (1990) 1.49
Cytoplasmic domain of P-selectin (CD62) contains the signal for sorting into the regulated secretory pathway. Mol Biol Cell (1992) 1.48
Regulatory serum lipoproteins: regulation of lymphocyte stimulation by a species of low density lipoprotein. J Immunol (1976) 1.48
Phosphatidylethanolamine augments factor VIIa-tissue factor activity: enhancement of sensitivity to phosphatidylserine. Biochemistry (1995) 1.47
Gender-related differences in thrombogenic factors predicting recurrent cardiac events in patients after acute myocardial infarction. The THROMBO Investigators. Am J Cardiol (2000) 1.47
Neoantigenic expressions engendered by plasmin cleavage of fibrinogen. J Immunol (1971) 1.47
Properties of recombinant human thromboplastin that determine the International Sensitivity Index (ISI). J Thromb Haemost (2004) 1.46
Adhesive receptor Mac-1 coordinates the activation of factor X on stimulated cells of monocytic and myeloid differentiation: an alternative initiation of the coagulation protease cascade. Proc Natl Acad Sci U S A (1988) 1.44
Tissue factor mRNA in THP-1 monocytic cells is regulated at both transcriptional and posttranscriptional levels in response to lipopolysaccharide. Mol Cell Biol (1991) 1.44
Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa. Proc Natl Acad Sci U S A (1996) 1.44
Glomerular complement components in human glomerulonephritis. J Clin Invest (1974) 1.43
Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway. J Cell Biol (1996) 1.41
Rapid and efficient incorporation of tissue factor into liposomes. J Thromb Haemost (2004) 1.40
Defense. FASEB J (1994) 1.39
Gene induction by coagulation factor Xa is mediated by activation of protease-activated receptor 1. Blood (2001) 1.37
Polyphosphate as a general procoagulant agent. J Thromb Haemost (2008) 1.36
An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiologic pH. J Clin Invest (1975) 1.36
Tumor necrosis factor production by human monocytes is a regulated event: induction of TNF-alpha-mediated cellular cytotoxicity by endotoxin. J Immunol (1986) 1.36
Alternatively spliced tissue factor induces angiogenesis through integrin ligation. Proc Natl Acad Sci U S A (2009) 1.35
Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro: two procoagulant activities are produced by peripheral blood mononuclear cells. J Clin Invest (1981) 1.34
Differential synthesis of spore coat proteins in prespore and prestalk cells of Dictyostelium. Proc Natl Acad Sci U S A (1982) 1.32
Structural biology of tissue factor, the initiator of thrombogenesis in vivo. FASEB J (1994) 1.32
Human T lymphocyte "E" rosette function. I. A process modulated by intracellular cyclic AMP. J Exp Med (1974) 1.31
Dissociation of antibody from erythrocyte surfaces by chaotropic ions. J Immunol (1971) 1.31
The kinetics and metabolic requirements for direct lymphocyte induction of human procoagulant monokines by bacterial lipopolysaccharide. J Immunol (1981) 1.31
A monoclonal antibody reacting with distinct adhesion molecules defines a transition in the functional state of the receptor CD11b/CD18 (Mac-1). J Immunol (1988) 1.31
Roles of the membrane-interactive regions of factor VIIa and tissue factor. The factor VIIa Gla domain is dispensable for binding to tissue factor but important for activation of factor X. J Biol Chem (1994) 1.30
Antibody mapping of tissue factor implicates two different exon-encoded regions in function. Biochem J (1991) 1.30
Tissue factor induction in human monocytes. Two distinct mechanisms displayed by different alloantigen-responsive T cell clones. J Clin Invest (1985) 1.27
Combined functional and immunochemical analysis of normal and abnormal human factor X. J Clin Invest (1979) 1.27
Recombinant soluble human tissue factor secreted by Saccharomyces cerevisiae and refolded from Escherichia coli inclusion bodies: glycosylation of mutants, activity and physical characterization. Biochem J (1995) 1.27
Role of the membrane surface in the activation of human coagulation factor X. J Biol Chem (1992) 1.27
Factor VIII coagulant activity and factor VIII-like antigen: independent molecular entities. J Exp Med (1973) 1.26
Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation (1995) 1.25
Expression and purification of a soluble tissue factor fusion protein with an epitope for an unusual calcium-dependent antibody. Protein Expr Purif (1992) 1.24
Factor-VIII-related antigen: multiple molecular forms in human plasma. Proc Natl Acad Sci U S A (1975) 1.24
Immunobiology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo. J Clin Invest (1973) 1.24
The mechanism of an inhibitory antibody on TF-initiated blood coagulation revealed by the crystal structures of human tissue factor, Fab 5G9 and TF.G9 complex. J Mol Biol (1998) 1.24
Monocytes can be induced by lipopolysaccharide-triggered T lymphocytes to express functional factor VII/VIIa protease activity. J Exp Med (1984) 1.23
Immune complex-induced human monocyte procoagulant activity. I. a rapid unidirectional lymphocyte-instructed pathway. J Exp Med (1981) 1.22